153 related articles for article (PubMed ID: 25425293)
41. F-actin reactive smooth muscle antibody in subjects with normal liver function.
Toh BH; Taylor R; Pollock W
Pathology; 2009; 41(6):572-5. PubMed ID: 19900107
[TBL] [Abstract][Full Text] [Related]
42. Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases.
Villalta D; Mytilinaiou MG; Elsner M; Hentschel C; Cuccato J; Somma V; Schierack P; Roggenbuck D; Bogdanos DP
Clin Chim Acta; 2015 Oct; 450():1-5. PubMed ID: 26220739
[TBL] [Abstract][Full Text] [Related]
43. Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study.
Clemente MG; Musu MP; Troncone R; Volta U; Congia M; Ciacci C; Neri E; Not T; Maggiore G; Strisciuglio P; Corazza GR; Gasbarrini G; Cicotto L; Sole G; Fasano A; De Virgiliis S
Am J Gastroenterol; 2004 Aug; 99(8):1551-6. PubMed ID: 15307876
[TBL] [Abstract][Full Text] [Related]
44. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
[TBL] [Abstract][Full Text] [Related]
45. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)].
Kanzler S; Bozkurt S; Herkel J; Galle PR; Dienes HP; Lohse AW
Dtsch Med Wochenschr; 2001 Apr; 126(16):450-6. PubMed ID: 11360449
[TBL] [Abstract][Full Text] [Related]
46. Autoantibodies in Autoimmune Hepatitis.
Muratori L; Deleonardi G; Lalanne C; Barbato E; Tovoli A; Libra A; Lenzi M; Cassani F; Muratori P
Dig Dis; 2015; 33 Suppl 2():65-9. PubMed ID: 26642213
[TBL] [Abstract][Full Text] [Related]
47. Thermolabile and calcium-dependent serum factor interferes with polymerized actin, and impairs anti-actin antibody detection.
Cançado EL; Abrantes-Lemos CP; Vilas-Boas LS; Novo NF; Carrilho FJ; Laudanna AA
J Autoimmun; 2001 Nov; 17(3):223-8. PubMed ID: 11712860
[TBL] [Abstract][Full Text] [Related]
48. Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1.
Orth T; Gerken G; Kellner R; Meyer zum Büschenfelde KH; Mayet WJ
J Hepatol; 1997 Jan; 26(1):37-47. PubMed ID: 9148020
[TBL] [Abstract][Full Text] [Related]
49. Autoimmune liver disease-related autoantibodies in patients with biliary atresia.
Pang SY; Dai YM; Zhang RZ; Chen YH; Peng XF; Fu J; Chen ZR; Liu YF; Yang LY; Wen Z; Yu JK; Liu HY
World J Gastroenterol; 2018 Jan; 24(3):387-396. PubMed ID: 29391761
[TBL] [Abstract][Full Text] [Related]
50. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA.
Leibovitch L; George J; Levi Y; Bakimer R; Shoenfeld Y
Immunol Lett; 1995 Dec; 48(2):129-32. PubMed ID: 8719111
[TBL] [Abstract][Full Text] [Related]
51. Autoantibodies and autoantigens in autoimmune hepatitis.
Strassburg CP; Manns MP
Semin Liver Dis; 2002 Nov; 22(4):339-52. PubMed ID: 12447706
[TBL] [Abstract][Full Text] [Related]
52. Detection of anti-lactoferrin antibodies and anti-myeloperoxidase antibodies in autoimmune hepatitis: a retrospective study.
Tan L; Zhang Y; Peng W; Chen J; Li H; Ming F
J Immunoassay Immunochem; 2014; 35(4):388-97. PubMed ID: 24547729
[TBL] [Abstract][Full Text] [Related]
53. [The significance of anti-soluble liver antigen/liver-pancreas in diagnosing and typing autoimmune hepatitis].
Zhao Y; Yan HP; Tan YF; Feng X; Liu Y; Cui D; Ma DM; Li WH; Zhang HP
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):283-6. PubMed ID: 17456317
[TBL] [Abstract][Full Text] [Related]
54. Smooth muscle antibodies and type 1 autoimmune hepatitis.
Muratori P; Muratori L; Agostinelli D; Pappas G; Veronesi L; Granito A; Cassani F; Terlizzi P; Lenzi M; Bianchi FB
Autoimmunity; 2002 Dec; 35(8):497-500. PubMed ID: 12765475
[TBL] [Abstract][Full Text] [Related]
55. [Autoimmune hepatitis: Immunological diagnosis].
Brahim I; Brahim I; Hazime R; Admou B
Presse Med; 2017 Nov; 46(11):1008-1019. PubMed ID: 28919271
[TBL] [Abstract][Full Text] [Related]
56. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
Klein R; Zanger UM; Berg T; Hopf U; Berg PA
Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
[TBL] [Abstract][Full Text] [Related]
57. Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis.
Matsumoto K; Miyake Y; Matsushita H; Ohnishi A; Ikeda F; Shiraha H; Takaki A; Nouso K; Yamamoto K
J Gastroenterol Hepatol; 2014 Jan; 29(1):110-5. PubMed ID: 23869988
[TBL] [Abstract][Full Text] [Related]
58. Serology in autoimmune hepatitis: A clinical-practice approach.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
Eur J Intern Med; 2018 Feb; 48():35-43. PubMed ID: 29056396
[TBL] [Abstract][Full Text] [Related]
59. Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody.
Bridoux-Henno L; Maggiore G; Johanet C; Fabre M; Vajro P; Dommergues JP; Reinert P; Bernard O
Clin Gastroenterol Hepatol; 2004 Sep; 2(9):825-30. PubMed ID: 15354284
[TBL] [Abstract][Full Text] [Related]
60. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease.
Gregorio GV; McFarlane B; Bracken P; Vergani D; Mieli-Vergani G
Autoimmunity; 2002 Dec; 35(8):515-9. PubMed ID: 12765477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
